NAVIFY® Tumor Board

Modernizing tumor board conferences


A cloud-based solution that enhances the efficiency of multidisciplinary tumor board meetings, supporting the essential functions of coordination, presentation and documentation—including automatically capturing, customizing and reporting key metrics essential for accreditation and quality measures.

Request a demo

NAVIFY® Tumor Board

Modernizing tumor board conferences


A cloud-based solution that enhances the efficiency of multidisciplinary tumor board meetings, supporting the essential functions of coordination, presentation and documentation—including automatically capturing, customizing and reporting key metrics essential for accreditation and quality measures.

Request a demo

Cancer care has many challenges.
Collaboration shouldn’t be one of them.

Without the support of a digital platform, tumor boards can be labor intensive and add additional administrative burden. Navigating among multiple systems, meeting participants can lose time and focus from achieving consensus on patient treatments.

NAVIFY Tumor Board aggregates and displays pertinent patient data all in one place to support multidisciplinary team decisions.

The next-generation tumor board solution from Roche

NAVIFY Tumor Board enables multidisciplinary oncology care teams to work together more effectively. Schedule meetings more easily. Conveniently and securely access, review, and share pertinent tumor board patient data across the network. Track and report accreditation analytics. Have clear sight into guidelines and available clinical trials. And—most importantly—quickly arrive at the best care plan for tumor board cases.

Benefits

Quicker
decisions

Enable quicker tumor board treatment decisions through integrated and standardized data.1

Improve
efficiency

Streamline and reduce burden for multidisciplinary team meeting preparation across the healthcare network.2

Anytime
anywhere

Easy access to secured patient data and virtual meetings can increase tumor board participation and quality.

Boost
quality

Capture accreditation and quality metrics as part of the tumor board process to support quality programs.

Accreditation and quality metric reporting built into your tumor board routine

For cancer centers, accreditation is a declaration of quality in patient care, operations and business practice. NAVIFY Tumor Board eliminates the challenges and risks associated with manual data entry by aggregating, measuring and providing accurate, timely reporting on the key metrics required for accreditation and quality improvement initiatives.

Improved efficiency at University of Missouri

NAVIFY Tumor Board helps physicians collect all of the data in one place so that we can make an informed decision.

Richard Hammer, MD
Vice-Chair of Pathology, University of Missouri

University of Missouri (MU) Ellis Fischel Cancer Center is recognized as a leader in cancer care, with state-of-the-art facilities and technologies. MU’s multidisciplinary, highly collaborative approach ensures a personalized treatment plan for each patient. Implementing NAVIFY Tumor Board across four tumor boards achieved a reduction in per-case discussion costs of 40-52%.*3

* The results are specific to MU. This is not a guarantee of results.

NAVIFY Tumor Board

Proven time savings in the first large prospective study2

Study method:

  • Preparation time collected across 227 tumor boards
  • 1,866 patient cases recorded

In this large prospective study across multiple tumor board specialties, NAVIFY Tumor Board demonstrated improved workflow efficiency, resulting in a significant and consistent reduction in overall preparation time.

30

average reduction in overall preparation time across three different tumor boards

Continuous and sustainable benefits with NAVIFY Tumor Board

Study confirmed process standardization2

A 76% variance (standard deviation) reduction in preparation time (p=0.036) was observed in the breast tumor board across 59 meetings.

76

variance reduction

Proven results from two large-scale prospective studies

Two prospective multi-year studies reveal how NAVIFY Tumor Board impacts multidisciplinary team meetings, specifically case preparation, case discussion time and postponement of cases in tumor boards.

Watch authors Dr. Richard D. Hammer and Dr. Matthew Prime discuss sustained benefits at the University of Missouri (MU) Ellis Fischel Cancer Center.

Value of virtual multidisciplinary tumor boards

Seamless, real-time decision-making

Virtual options support optimization of clinicians’ time from preparation to meeting conduction.

Get the white paper

Explore
more

Still image featuring specialists at a multidisciplinary tumor board meeting

See how NAVIFY Tumor Board has made a difference at the University of Missouri

Play video

A partial image of the cover of NAVIFY Tumor Board brochure

Explore how NAVIFY Tumor Board supports personalized treatment decisions

Read more

See how NAVIFY Tumor Board streamlines the entire tumor board process

Play video

  1. Fowler, D., et al. (2019) ‘The impact of a digital solution on case discussion at tumor boards’, American Society of Clinical Oncology.
  2. Hammer R. D., et al. (2020) ‘Digital Tumor Board Solutions Have Significant Impact on Case Preparation’, JCO Clinical Cancer Informatics, 4(4), p757-768.
  3. Hammer, RD, Fowler D, Sheets L, Siadimas A, Guo C, Prime M. A digital tumor board solution impacts case discussion time and postponement of cases in tumor boards. Health and Technology 2021-02-27 DOI 10.1007/s12553-021-00533-x.

* The results are specific to Ellis Fischel based on multiple Ellis Fischel tumor board sites. The data is available upon request. This is not a guarantee of results.